Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (K23DK 118179)
U.S. Department of Veterans Affairs (RCS 11-222)
Received: 22 November 2021
Accepted: 9 January 2022
First Online: 28 January 2022
: This study was approved by the University of Michigan institutional review board (HUM00201535) on September 10, 2021.
: Not applicable.
: GDB receives consulting fees from Pfizer/Bristol-Myers Squibb, Jansen, and Acelis Connected Health. All other authors declare that they have no competing interests.